APA

Karapanagiotou E. M., Charpidou A., Tzannou I., Dilana K., Kotteas E., Tourkantonis I., Kosmas E., Provata A. & Syrigos K. (20081222). A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer. : Medical oncology (Northwood, London, England).

Chicago

Karapanagiotou Eleni M, Charpidou Adrianni, Tzannou Ifigenia, Dilana Kalliopi, Kotteas Elias, Tourkantonis Ioannis, Kosmas Epaminondas, Provata Aspasia and Syrigos Kostas. 20081222. A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer. : Medical oncology (Northwood, London, England).

Harvard

Karapanagiotou E. M., Charpidou A., Tzannou I., Dilana K., Kotteas E., Tourkantonis I., Kosmas E., Provata A. and Syrigos K. (20081222). A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer. : Medical oncology (Northwood, London, England).

MLA

Karapanagiotou Eleni M, Charpidou Adrianni, Tzannou Ifigenia, Dilana Kalliopi, Kotteas Elias, Tourkantonis Ioannis, Kosmas Epaminondas, Provata Aspasia and Syrigos Kostas. A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer. : Medical oncology (Northwood, London, England). 20081222.